According to filings with the U.S. Securities and Exchange Commission, CyMedica Orthopedics is raising $6,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Robert Morocco played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CyMedica Orthopedics
CyMedica Orthopedics has developed combined therapy-based and digital health technology platform to effectively treat muscles weakened by knee osteoarthritis or surgery. This award-winning digital wearable technology, e-vive, is the only FDA cleared, app-based muscle strengthening and patient engagement system uniquely designed to deliver comfortable and individualized muscle stimulation therapy. e-vive provides a platform to improve clinical outcomes while collecting rehabilitation data useful in measuring and promoting patient progress. Muscle weakness is considered one of the most prevalent underlying clinical conditions associated with knee osteoarthritis and the rehabilitation challenges facing patients recovering from knee procedures.

To learn more about CyMedica Orthopedics, visit http://www.cymedicaortho.com/

Contact:
Robert Morocco, President and Chief Executive Officer
480-606-8680
https://www.linkedin.com/in/robert-morocco-05043816/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.